---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-24-000059"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T08:23:53.851329+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Lifecore gets $5.5M prepayment from Alcon; annual meeting set for Aug 15, 2024

## Summary
- Alcon Research paid $5.5M prepayment for future product purchases; credits apply in 2026.
- Lifecore subsidiary amends contract manufacturing agreement with Alcon, effective May 2, 2024.
- Board sets 2023 annual meeting for Aug 15, 2024; shareholder proposals due by May 18, 2024.
- Prepayment provides $5.5M near-term liquidity; customer commitment indicator.

## SEC filing metadata
- accession: 0001005286-24-000059
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 5.08, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000059/0001005286-24-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000059/lndc-20240502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-24-000059
- JSON: https://secwatch.observer/filing/0001005286-24-000059.json
- Plain text: https://secwatch.observer/filing/0001005286-24-000059.txt

## Key facts
- Material Agreements
  LIFECORE BIOMEDICAL, INC. DE amended Amendment No. 1 with Alcon Research, LLC valued at $5,500,000 (effective 2024-05-02).
  - Action: amendment
  - Agreement: supply
  - Counterparty: Alcon Research, LLC
  - Value: $5,500,000
  - Effective: 2024-05-02
  source text: On May 2, 2024, Lifecore Biomedical, LLC, a subsidiary of Lifecore Biomedical, Inc. (the “Company”), entered into Amendment No. 1 (the “ARCMA Amendment”) to Amended and Restated Contract Manufacturing Agreement with Alcon Research, LLC (the “ARCMA”), under which Alcon made a prepayment in the amount of $5,500,000 toward future purchases of products under the ARCMA.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000059/0001005286-24-000059-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.